Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of delpazolid add-on therapy in Patients with Refractory Mycobacterium abscessus Complex Pulmonary disease


Clinical Trial Description

Delpazolid, which demonstrates effects similar to other oxazolidinone-class drugs and has confirmed good safety, aims to evaluate its efficacy in MABC-PD patients who are unresponsive to guideline-based treatments ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06004037
Study type Interventional
Source LigaChem Biosciences, Inc.
Contact
Status Active, not recruiting
Phase Phase 2
Start date January 16, 2024
Completion date May 29, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT03532438 - WGS of NTM From Sputum of NTM Lung Disease Patients and From Their Environments
Recruiting NCT04921943 - Hypertonic Saline for MAC Phase 4
Recruiting NCT04294043 - IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study) Phase 1
Recruiting NCT05280886 - Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB)
Completed NCT04024423 - Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis
Completed NCT03748992 - A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection Phase 2
Enrolling by invitation NCT06262282 - Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria
Recruiting NCT03672630 - Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease Phase 2/Phase 3
Recruiting NCT03120481 - Controls for Respiratory Diseases N/A